Bandaram Pharma Packtech Limited

BSE: 524602
Bandaram Pharma Packtech Limited - manufacturing in Bangalore, Karnataka, India. FY 2026 financials & compliance.
CIN L93090KA1993PLC159827 Incorporated 05 August 1993 ROC Bangalore HQ Bangalore, Karnataka, India
Active Listed - BSE: 524602 Public Limited Company manufacturing
Data last updated
Market Cap
₹36.47 Cr
BANDARAM · BSE
Share Price
₹20.29
+1.50% today
Revenue
₹62.92 Cr
FY 2025-26 · +75.8% YoY
EBITDA
₹2.90 Cr
Margin 4.6%
Net Profit
₹0.45 Cr
FY 2025-26 · -54.1% YoY
P/E (TTM)
36.1x
P/B 1.3x

About Bandaram Pharma Packtech Limited

Data last updated:

Bandaram Pharma Packtech Limited is a public limited company based in Bangalore, Karnataka, India. It specialises in paper and packaging products, a part of the broader manufacturing sector. Incorporated on 05 August 1993, the company has been in operation for over 33 years.

Registered with ROC Bangalore under CIN L93090KA1993PLC159827. Listed on BSE: 524602.

Capital: an authorised share capital of ₹19 Cr and a paid-up capital of ₹17.97 Cr. It is led by directors including Bhandaram Sathyavathi and Bhandaram Premsai Reddy.

Last AGM: 29 September 2025. Financial statements filed for year ended 31 March 2025. Office: 601 5Th Floor Oxford Towers Opp To Leela Palace Hotel Old Airport Road Kodihalli, Bangalore, Karnataka, India – 560008.

As per the latest consolidated financials for FY 2025-26, the company reported a revenue of ₹62.92 Cr, a growth of 70.24% compared to the previous year. The net worth stands at ₹26.78 Cr (up 111.7% YoY). Total assets are valued at ₹55.31 Cr (up 67.71% YoY).

The company is associated with 2 brands - Shiva Medicare, Bandaram Pharma Packtech. As per MCA filings, the company has open charges of ₹50 Lakh and satisfied charges of ₹18.42 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website shivamedicare.com.

Company Details of Bandaram Pharma Packtech Limited
CIN L93090KA1993PLC159827
Registration Number 159827
Incorporation Date 05 August 1993
ROC Bangalore
Listing Status Listed (BSE: 524602)
Company Status Active
Date of Last AGM 29 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Key People
Deepak Bandaram Managing Director Bhandaram Sathyavathi Director Bhandaram Premsai Reddy Director
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    shivamedicare.com
  • Social Media
    Locked
  • Registered Address
    601 5Th Floor Oxford Towers Opp To Leela Palace Hotel Old Airport Road Kodihalli, Bangalore, Karnataka, India – 560008
  • Industry
    Manufacturing, Paper & Packaging Products
Company report
Bandaram Pharma Packtech Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Bandaram Pharma Packtech Limited report

Financials, compliance, directors, charges, ownership and filings for Bandaram Pharma Packtech Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Bandaram Pharma Packtech

Bandaram Pharma Packtech has 4 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L93090KA1993PLC159827, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
L93090KA1993PLC159827Current
L93090TG1993PLC088165Previous
L93090DL1993PLC186295Previous
L93090TN1993PLC025563Previous
L93090AP1993PLC088165Previous

Associated Brands with Bandaram Pharma Packtech

Bandaram Pharma Packtech operates two associated brands: Shiva Medicare and Bandaram Pharma Packtech. Each brand links to its own profile.

BrandDescriptionWebsite
Shiva Medicare
Manufacturer of auto retractable safety syringeshivamedicare.com
Bandaram Pharma Packtech
Pharmaceutical packaging solutions are provided by Bandaram Pharma Packtech.bandaram.com

Competitors & Alternatives of Bandaram Pharma Packtech

Brands and companies operating in the same space as Bandaram Pharma Packtech Limited include Legacy Pharma Solutions, Natural Capsules, SCHOTT Poonawalla and 5 more.

CompetitorDescriptionLocationFounded
Legacy Pharma Solutions Legacy Pharma Solutions Contract pharmaceutical packaging companyEarth City, United States, United States2003
Natural Capsules Natural Capsules Manufacturing and supply chain services for biopharma sector are provided.Bengaluru, India, India1993
SCHOTT Poonawalla SCHOTT Poonawalla Packaging solutions for pharmaceutical and biotech industries are provided.Mumbai, India, India1990
Ideal Cures Ideal Cures Manufacturer of pharmaceutical excipients and coatings systems for solid oral dosage formsMumbai, India, India1999
Sanner Sanner Plastic packaging solutions for pharmaceutical products are manufactured.Bensheim, Germany, Germany1894
Cilicant Cilicant Drugs for the biopharma sector are manufactured and supplied.Pune, India, India2011
Nutra-Med Packaging Nutra-Med Packaging Provider of drugs packaging servicesHanover, United States, United States1999
Eulysis Eulysis Diabetes management and lifestyle modification services are provided.Cambridge, United States, United States2010

Auditor Details of Bandaram Pharma Packtech

Bandaram Pharma Packtech Limited is audited by M M REDDY & CO for the financial year 2023.

NameStatusAppointment DateCessation Date
M M REDDY & COLockedLockedLocked
Premium access

Complete auditor history for Bandaram Pharma Packtech Limited

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Bandaram Pharma Packtech Limited

Bandaram Pharma Packtech has 7 current directors and 26 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Bhandaram SathyavathiDirector07 Mar 20224 Years 6 MonthsCurrent
Bhandaram Premsai Reddy
Also directs: BJN Healthcare Services Private Limited
Director07 Mar 20224 Years 6 MonthsCurrent
Suryaprakasa Rao Bommisetti
Also directs: Jeevan Scientific Technology Limited, Samsrita Labs Limited
Director07 Mar 20224 Years 6 MonthsCurrent
Deepak Bandaram
Also directs: VSR Paper and Packaging Limited, RCL Paper and Packagings Limited
Managing Director07 Feb 20233 Years 7 MonthsCurrent
Mounika Pammi
Also directs: Ratiorise Capital Advisory LLP, Midland Polymers Limited, Variman Global Enterprises Limited and 4 more
Director20 Jun 20251 Years 3 MonthsCurrent
Suman Mallu
Also directs: VSR Paper and Packaging Limited
Director01 Sep 20233 Years 1 MonthsCurrent
Showing 6 of 7 current directors. View all directors

Financials of Bandaram Pharma Packtech Limited FY 2025-26 filings available

Bandaram Pharma Packtech Limited reported revenue of ₹62.92 Cr (up 70.24% YoY) for FY 2025-26.

Financial Highlights

FY 2025-26 · Consolidated
Revenue
₹62.92 Cr
+70.2% YoY
EBITDA
₹2.90 Cr
+3.2% YoY
Profit After Tax
₹0.45 Cr
-54.1% YoY
Net Worth
₹26.78 Cr
+111.7% YoY
Total Assets
₹55.31 Cr
+67.7% YoY
Total Debt
₹23.95 Cr
+39.7% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23
Income statement
Revenue62.9236.9634.0818.73
Revenue growth+75.8%+9.3%+77.8%+9997.0%
EBITDA2.902.812.821.15
EBITDA margin+4.6%+7.6%+8.3%+6.1%
Profit before tax0.441.301.190.32
Net profit0.450.980.950.13
Net profit margin+0.7%+2.7%+2.8%+0.7%
EPS (₹)0.250.830.790.47
Balance sheet
Total assets55.3132.9827.2719.34
Net worth26.7812.6512.283.08
Total debt23.9517.1512.2014.20
Cash & bank0.720.120.040.16
Net working capital36.5625.0221.3514.27
Cash flow
Cash from operations(4.92)(4.93)(4.13)(1.10)
Cash from investing0.00(0.08)(1.58)(5.30)
Cash from financing5.535.095.594.47
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue23.9526.2614.8413.728.108.4910.007.11
Revenue growth (YoY)+195.7%+209.3%+48.4%+93.0%-28.8%-36.8%+35.9%-3.4%
Other income0.000.010.000.010.000.090.000.00
EBITDA1.540.821.000.450.630.540.661.09
EBITDA margin+6.4%+3.1%+6.7%+3.3%+7.8%+6.4%+6.6%+15.3%
Depreciation0.200.250.140.140.130.530.150.15
Interest0.420.460.330.250.46(0.10)0.240.26
Profit before tax0.920.120.530.070.040.200.270.68
Tax0.240.030.180.020.010.050.280.00
Net profit0.680.090.350.050.030.15(0.01)0.68
EPS (₹)0.110.050.110.030.020.13(0.01)0.31
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2017-18
Income statement
Revenue10.9612.2314.8410.090.000.000.00
Revenue growth-0.1%-17.3%+49.5%-0.0%-99.1%+2.8%
EBITDA(1.17)0.090.160.27(0.01)(0.01)(1.12)
EBITDA margin-10.7%+0.7%+1.1%+2.7%---
Profit before tax(1.16)0.170.170.27(0.01)(0.03)(1.16)
Net profit(1.16)0.120.130.20(0.01)(0.03)(1.16)
Net profit margin-10.6%+1.0%+0.9%+2.0%---
EPS (₹)(0.64)0.120.110.68(0.03)(0.14)0.00
Balance sheet
Total assets27.4015.5912.227.482.990.100.39
Net worth22.8812.1012.203.072.99(2.32)(1.78)
Total debt4.513.490.024.410.001.451.20
Cash & bank0.260.020.040.092.080.000.00
Net working capital5.506.498.304.952.99(0.39)(0.18)
Cash flow
Cash from operations1.21(3.25)(3.26)(3.87)2.920.00(0.98)
Cash from investing(2.00)0.00(1.40)(2.53)(1.55)0.000.42
Cash from financing1.033.234.614.400.720.000.00
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue2.998.201.680.330.763.712.633.17
Revenue growth (YoY)+293.4%+121.0%-36.1%-89.6%-72.1%+147.3%-53.9%-10.5%
Other income0.000.000.000.010.000.090.000.00
Total expenses3.348.531.890.681.033.752.582.83
EBITDA(0.35)(0.33)(0.21)(0.35)(0.27)(0.04)0.050.34
EBITDA margin-11.7%-4.0%-12.5%-106.1%-35.5%-1.1%+1.9%+10.7%
Depreciation0.000.000.000.000.000.000.000.00
Interest0.000.000.000.000.000.000.000.00
Profit before tax(0.35)(0.33)(0.21)(0.34)(0.27)0.050.050.34
Tax0.000.000.000.000.000.010.030.00

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 03 Oct 2026
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue23.9526.2614.8413.728.108.4910.007.11
Revenue growth (YoY)+195.7%+209.3%+48.4%+93.0%-28.8%-36.8%+35.9%-3.4%
Other income0.000.010.000.010.000.090.000.00
EBITDA1.540.821.000.450.630.540.661.09
EBITDA margin+6.4%+3.1%+6.7%+3.3%+7.8%+6.4%+6.6%+15.3%
Depreciation0.200.250.140.140.130.530.150.15
Interest0.420.460.330.250.46(0.10)0.240.26
Profit before tax0.920.120.530.070.040.200.270.68
Tax0.240.030.180.020.010.050.280.00
Net profit0.680.090.350.050.030.15(0.01)0.68
EPS (₹)0.110.050.110.030.020.13(0.01)0.31
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23
Revenue62.9236.9634.0818.73
Revenue growth+75.8%+9.3%+77.8%+9997.0%
Other income0.020.090.030.19
Total expenses60.0234.1531.2617.58
Employee cost0.002.962.330.64
EBITDA2.902.812.821.15
EBITDA margin+4.6%+7.6%+8.3%+6.1%
Depreciation0.970.610.730.59
Interest1.510.990.930.43
Profit before tax0.441.301.190.32
Tax(0.01)0.320.240.07
Net profit0.450.980.950.13
Net profit margin+0.7%+2.7%+2.8%+0.7%
EPS (₹)0.250.830.790.47
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23
Equity & liabilities
Share capital17.9712.0012.003.00
Reserves & surplus8.810.650.280.08
Shareholders' funds (net worth)26.7812.6512.283.08
Minority interest4.583.172.792.05
Secured loans14.9210.521.781.97
Unsecured loans9.036.6310.4212.23
Total debt23.9517.1512.2014.20
Total liabilities55.3132.9827.2719.34
Assets
Gross block15.223.955.915.03
Net block15.223.954.485.03
Capital work in progress0.000.000.000.00
Investments0.001.401.400.00
Inventories12.948.516.472.71
Sundry debtors31.3518.7614.526.62
Cash & bank balances0.720.120.040.16
Loans & advances11.983.505.035.57
Total current assets56.9930.8926.0615.06
Total current liabilities20.435.874.710.79
Net working capital36.5625.0221.3514.27
Total assets55.3132.9827.2719.34
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23
Opening cash0.120.040.162.09
Net cash from operating activities(4.92)(4.93)(4.13)(1.10)
Net cash from investing activities0.00(0.08)(1.58)(5.30)
Net cash from financing activities5.535.095.594.47
Net change in cash0.600.08(0.11)(1.93)
Closing cash0.720.120.040.16
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23
Growth
Sales growth+70.2%+8.5%+82.0%+9997.0%
EBITDA growth+3.2%-0.4%+145.2%+9997.0%
PBT growth-66.2%+9.2%+271.9%+9997.0%
Net income growth-54.1%+3.2%+630.8%+9997.0%
Revenue CAGR (3Y)+49.8%---
EBITDA CAGR (3Y)+36.1%---
Profitability & leverage
Net income margin+0.7%+2.7%+2.8%+1.3%
Return on capital employed-+8.5%+10.2%+4.4%
Return on net worth-+7.9%+12.4%+8.4%
Debt / equity-1.181.724.61
Long-term debt / equity-0.550.802.48
Interest cover78.2445.0044.5076.79
Efficiency & per share
Fixed asset turnover-6.216.233.72
Inventory turnover-4.937.426.91
Debtors turnover-2.223.222.83
EPS (₹)0.250.830.790.47
Dividend per share (₹)0.000.100.100.10
Book value per share (₹)0.0010.5410.2310.28
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue2.998.201.680.330.763.712.633.17
Revenue growth (YoY)+293.4%+121.0%-36.1%-89.6%-72.1%+147.3%-53.9%-10.5%
Other income0.000.000.000.010.000.090.000.00
Total expenses3.348.531.890.681.033.752.582.83
EBITDA(0.35)(0.33)(0.21)(0.35)(0.27)(0.04)0.050.34
EBITDA margin-11.7%-4.0%-12.5%-106.1%-35.5%-1.1%+1.9%+10.7%
Depreciation0.000.000.000.000.000.000.000.00
Interest0.000.000.000.000.000.000.000.00
Profit before tax(0.35)(0.33)(0.21)(0.34)(0.27)0.050.050.34
Tax0.000.000.000.000.000.010.030.00
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2017-18
Revenue10.9612.2314.8410.090.000.000.00
Revenue growth-0.1%-17.3%+49.5%-0.0%-99.1%+2.8%
Other income0.010.090.030.000.000.000.00
Total expenses12.1312.1414.689.820.010.011.12
Employee cost0.001.101.140.080.000.000.37
EBITDA(1.17)0.090.160.27(0.01)(0.01)(1.12)
EBITDA margin-10.7%+0.7%+1.1%+2.7%---
Depreciation0.000.010.020.000.000.020.03
Interest0.000.000.000.000.000.000.01
Profit before tax(1.16)0.170.170.27(0.01)(0.03)(1.16)
Tax0.000.050.040.070.000.000.00
Net profit(1.16)0.120.130.20(0.01)(0.03)(1.16)
Net profit margin-10.6%+1.0%+0.9%+2.0%---
EPS (₹)(0.64)0.120.110.68(0.03)(0.14)0.00
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2017-18
Equity & liabilities
Share capital17.9712.0012.003.003.002.282.28
Reserves & surplus4.910.100.200.07(0.01)(4.60)(4.06)
Shareholders' funds (net worth)22.8812.1012.203.072.99(2.32)(1.78)
Secured loans0.000.000.000.000.000.000.00
Unsecured loans4.513.490.024.410.001.451.20
Total debt4.513.490.024.410.001.451.20
Total liabilities27.4015.5912.227.482.990.100.39
Assets
Gross block0.030.030.030.030.000.110.21
Net block0.010.010.010.030.000.110.18
Capital work in progress0.000.000.000.000.000.000.00
Investments17.853.913.912.510.000.000.00
Inventories2.081.642.160.550.000.000.00
Sundry debtors10.676.622.402.690.000.000.00
Cash & bank balances0.260.020.040.092.080.000.00
Loans & advances1.701.844.832.410.920.770.77
Total current assets14.7110.129.435.743.000.770.77
Total current liabilities9.213.631.130.790.011.160.95
Net working capital5.506.498.304.952.99(0.39)(0.18)
Total assets27.4015.5912.227.482.990.100.39
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2017-18
Opening cash0.020.040.092.080.000.000.57
Net cash from operating activities1.21(3.25)(3.26)(3.87)2.920.00(0.98)
Net cash from investing activities(2.00)0.00(1.40)(2.53)(1.55)0.000.42
Net cash from financing activities1.033.234.614.400.720.000.00
Net change in cash0.24(0.02)(0.04)(2.00)2.080.00(0.56)
Closing cash0.260.020.040.092.080.000.00
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2017-18
Growth
Sales growth-10.4%-17.6%+47.1%+9997.0%+9997.0%+9997.0%+9997.0%
EBITDA growth--43.8%-40.7%+9998.0%0.0%+99.1%-2.8%
PBT growth-0.0%-37.0%+9998.0%+66.7%+97.4%-6.4%
Net income growth--7.7%-35.0%+9998.0%+66.7%+97.4%-6.4%
Revenue CAGR (3Y)+2.8%------
EBITDA CAGR (3Y)-----79.1%-41.5%+382.0%
Profitability & leverage
Net income margin-10.6%+1.0%+0.9%+2.0%---
Return on capital employed-+1.4%+1.7%+5.2%0.0%0.0%0.0%
Return on net worth-+1.2%+1.7%+6.6%0.0%0.0%0.0%
Debt / equity-0.140.290.732.170.000.00
Long-term debt / equity-0.140.290.732.170.000.00
Interest cover0.000.000.000.000.000.00-0.87
Efficiency & per share
Fixed asset turnover-611.50494.67672.670.000.000.00
Inventory turnover-6.4410.9536.690.000.000.00
Debtors turnover-2.715.837.500.000.000.00
EPS (₹)(0.64)0.120.110.68(0.03)(0.14)0.00
Dividend per share (₹)0.000.100.100.100.000.000.00
Book value per share (₹)0.0010.0910.1710.259.97(10.18)(7.82)
Want more history and ratios?
You're viewing the latest exchange-filed financials for Bandaram Pharma Packtech Limited. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Shareholding Pattern of Bandaram Pharma Packtech Limited

Shareholding for the quarter ended Sep 2026: promoters hold 62.70%, foreign institutional investors hold 0.00%, domestic institutional investors hold 0.00% and retail and other public shareholders hold 37.30%.

Promoters: 62.70%Retail & Others: 37.30%
Sep 2026
QUARTER
62.70% Promoters
37.30% Retail & Others
Promoter holding - history
Now 62.70% · Sep 2026High 75.00% · Dec 2025Low 62.60% · Mar 2026
61%64.8%68.5%72.3%76%Dec 2025Mar 2026Jun 2026Sep 2026Dec 2025: 75.00%Mar 2026: 62.60%Jun 2026: 62.70%Sep 2026: 62.70%75.00%62.60%62.70%
Shareholding trend - last 6 quarters
Sep 2026Jun 2026Mar 2026Dec 2025
Promoters62.70%62.70%62.60%75.00%
Public37.30%37.30%37.40%25.00%

Charges & Borrowings of Bandaram Pharma Packtech

Open charges
₹50 Lakh
Satisfied charges
₹18.42 Cr
Breakdown by lending institutions
State Bank of India;₹0.50 Cr
Latest charge details
DateLenderAmountStatus
30 May 1992State Bank of India;₹25 LakhOpen
30 May 1992State Bank of India;₹25 LakhOpen
18 Jan 2024Others₹10 CrSatisfied
16 Jun 1998State Bank of India;₹7 CrSatisfied
30 Apr 1996Union Bank of India₹1.42 CrSatisfied

Total charge records: 5 View all charges

Employees and EPFO Compliance at Bandaram Pharma Packtech

Employment history and EPFO contributions of people linked to Bandaram Pharma Packtech.

Premium access

Employee and EPFO history for Bandaram Pharma Packtech Limited

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Bandaram Pharma Packtech

Premium access

GST registrations and filing compliance for Bandaram Pharma Packtech Limited

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Bandaram Pharma Packtech

Premium access

Credit ratings, litigation, and regulatory alerts for Bandaram Pharma Packtech Limited

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Bandaram Pharma Packtech

Premium access

MSME payment history for Bandaram Pharma Packtech Limited

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Bandaram Pharma Packtech

Premium access

Corporate group structure for Bandaram Pharma Packtech Limited

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Bandaram Pharma Packtech

Premium access

MCA filings and documents for Bandaram Pharma Packtech Limited

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Bandaram Pharma Packtech

Directors
30 Jan 2026
Eswar Reddy Putturu was appointed as a Director on 30 Jan 2026 & has been associated with this company since 8 months 4 days.
Charges
23 Dec 2025
A charge registered on 18 Jan 2024 via Charge ID 100856382 with Others was fully satisfied on 23 Dec 2025.
Activity
29 Sep 2025
Bandaram Pharma Packtech Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Directors
20 Jun 2025
Mounika Pammi was appointed as a Director on 20 Jun 2025 & has been associated with this company since 1 year 3 months.
Activity
31 Mar 2025
Bandaram Pharma Packtech Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore.
Charges
18 Jan 2024
A charge with Others amounted to Rs. 10.00 Cr with Charge ID 100856382 was registered on 18 Jan 2024.

Recent News on Bandaram Pharma Packtech

Frequently Asked Questions about Bandaram Pharma Packtech Limited

Bandaram Pharma Packtech is an active public limited company in the manufacturing sector based in Bangalore, Karnataka, India. It was incorporated on 05 August 1993 (33+ years old) and is registered under CIN L93090KA1993PLC159827. Listed on BSE: 524602.

Bandaram Pharma Packtech reported revenue of ₹62.92 Cr for FY 2025-26 (up 70.24% YoY) based on consolidated financials.

The current directors of Bandaram Pharma Packtech are:

The primary industry of Bandaram Pharma Packtech is manufacturing. The company specifically operates in paper and packaging products. The company is currently active in this sector.

Yes. Bandaram Pharma Packtech is listed on BSE with code 524602.

Bandaram Pharma Packtech can be reached at the registered office: 601 5Th Floor Oxford Towers Opp To Leela Palace Hotel Old Airport Road Kodihalli, Bangalore, Karnataka, India – 560008, or through the website shivamedicare.com.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available